Literature DB >> 25316157

RNA-binding proteins, multifaceted translational regulators in cancer.

Laurence Wurth1, Fátima Gebauer2.   

Abstract

RNA-binding proteins (RBPs) orchestrate transcript fate and function. Even though alterations in post-transcriptional events contribute to key steps of tumor initiation and progression, RBP-mediated control has remained relatively unexplored in cancer. Here, we discuss examples of this promising field focusing on translation regulation, and highlight the variety of molecular mechanisms by which RBPs impinge on translation with consequences for tumorigenesis. This article is part of a Special Issue entitled: Translation and Cancer.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Cytoplasmic polyadenylation; IRES; RNA-binding protein; Translation

Mesh:

Substances:

Year:  2014        PMID: 25316157     DOI: 10.1016/j.bbagrm.2014.10.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  55 in total

Review 1.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

Review 2.  RNA regulons in cancer and inflammation.

Authors:  Laura Simone Bisogno; Jack Donald Keene
Journal:  Curr Opin Genet Dev       Date:  2017-11-22       Impact factor: 5.578

3.  IGF2 mRNA binding protein 3 (IMP3) mediated regulation of transcriptome and translatome in glioma cells.

Authors:  Shruti Bhargava; Vikas Patil; Riyaz Ahmad Shah; Kumaravel Somasundaram
Journal:  Cancer Biol Ther       Date:  2017-12-19       Impact factor: 4.742

Review 4.  Circular RNAs: Functions and Prospects in Glioma.

Authors:  Zheng Hao; Si Hu; Zheng Liu; Weixin Song; Yeyu Zhao; Meihua Li
Journal:  J Mol Neurosci       Date:  2018-11-20       Impact factor: 3.444

5.  CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.

Authors:  Shruti Lal; Edwin C Cheung; Mahsa Zarei; Ranjan Preet; Saswati N Chand; Nicole C Mambelli-Lisboa; Carmella Romeo; Matthew C Stout; Eric Londin; Austin Goetz; Cinthya Y Lowder; Avinoam Nevler; Charles J Yeo; Paul M Campbell; Jordan M Winter; Dan A Dixon; Jonathan R Brody
Journal:  Mol Cancer Res       Date:  2017-02-27       Impact factor: 5.852

6.  Effects of HuR downregulation on anaplastic thyroid cancer cells.

Authors:  Lorenzo Allegri; Catia Mio; Diego Russo; Sebastiano Filetti; Federica Baldan
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

7.  Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.

Authors:  M-H Kang; K J Jeong; W Y Kim; H J Lee; G Gong; N Suh; B Győrffy; S Kim; S-Y Jeong; G B Mills; Y-Y Park
Journal:  Oncogene       Date:  2016-09-05       Impact factor: 9.867

8.  BOPC1 Enantiomers Preparation and HuR Interaction Study. From Molecular Modeling to a Curious DEEP-STD NMR Application.

Authors:  Serena Della Volpe; Roberta Listro; Michela Parafioriti; Marcello Di Giacomo; Daniela Rossi; Francesca Alessandra Ambrosio; Giosuè Costa; Stefano Alcaro; Francesco Ortuso; Anna K H Hirsch; Francesca Vasile; Simona Collina
Journal:  ACS Med Chem Lett       Date:  2020-01-28       Impact factor: 4.345

Review 9.  RNP transport in cell biology: the long and winding road.

Authors:  Carolina Eliscovich; Robert H Singer
Journal:  Curr Opin Cell Biol       Date:  2017-03-01       Impact factor: 8.382

Review 10.  New frontiers in translational control of the cancer genome.

Authors:  Morgan L Truitt; Davide Ruggero
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.